TRADE TENSION RISES: TRUMP ANNOUNCES 100% TARRIF ON IMPORTED MEDICINES

Date:

Share post:

TRADE TENSION RISES: TRUMP ANNOUNCES 100% TARRIF ON IMPORTED MEDICINES

PharmaGenDRx News Bureau- 27th September,2025

12:00 PM IST

On Thursday, 25th of September, 2025, in a rally in Ohio, U.S. president Donald Trump announced the imposition of a 100% tariff on imported medicines of all kinds, emphasising the need for economic independence and bringing back drug manufacturing to the American soil being major driving forces behind such determinant action, triggering concern across pharmaceutical industry.

Though the tariffs are imported globally, most Asian Countries such as India, China and Japan, are the major exporters of Pharmaceutical and generic products to United States. This sudden tariff could potentially lead to exponentially high prices, supply chain disruptions and limited access to health care to the patients in the United States.

Even though health experts and economists have cautioned that these tariffs could have major drawbacks in promoting optimal healthcare to the patients of their country, Trump backed his notion by stating that “flooding” of products into the country seemed unfair.This move has intensified political debates and healthcare sovereignty, drug pricing and is taking a dig at globalization , earning praise and criticism from both political and industrial spectra.

By Arundhuti Chatterjee & Sharon Bose

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Cognizant Expands Strategic Partnership with Novartis to Transform Global IT Operations using Agentic AI

Cognizant has announced a new five-year, AI-enabled integrated IT operations agreement with Novartis, expanding a strategic relationship that...

Seven Clinical Trial Ethics Panels Lose CDSCO Registration in Compliance Crackdown

The Central Drugs Standard Control Organisation (CDSCO) has withdrawn registration certificates from seven Ethics Committees nationwide after risk-based...

From Research to Revolution: Novo Nordisk Shares Oral GLP-1 Breakthrough Story

Novo Nordisk has shared the scientific journey behind turning an injectable biologic medicine into a pill — a...

Biozenta Lifescience to Build ₹1,250 Crore Oncology Plant in Barabanki, UP

Biozenta Lifescience Pvt. Ltd., a global leader in oncology medicines, has announced plans to establish a state-of-the-art manufacturing facility in Barabanki, Uttar...